- Report
- May 2025
- 180 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 180 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 190 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 182 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 194 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 188 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 197 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 187 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 187 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 196 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 195 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 199 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 184 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 136 Pages
Global
From €2722EUR$2,999USD£2,294GBP
- Report
- May 2025
- 198 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 199 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 187 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 100 Pages
Global
From €4447EUR$4,900USD£3,749GBP
- Report
- May 2025
- 175 Pages
Global
From €4075EUR$4,490USD£3,435GBP
- Report
- May 2025
- 175 Pages
Global
From €4075EUR$4,490USD£3,435GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more